Received Feb 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 6 | 3043822 | IM / LA |
got the vaccine in December and now has COVID; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (got the vaccine in December and now has COVID) in a 74-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3043822) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: J and j covid-19 Vaccine (Dose 1) in October 2021; for COVID-19 prophylaxis: Moderna covid-19 vaccine (Dose 2) in April 2022, Moderna covid-19 vaccine (Dose 3) in April 2023, Moderna covid-19 vaccine (Dose 4) in October 2023 and Moderna covid-19 vaccine (Dose 5) in April 2024. Past adverse reactions to the above products included COVID-19 with J and j covid-19 Vaccine; and No adverse effect with Moderna covid-19 vaccine, Moderna covid-19 vaccine, Moderna covid-19 vaccine and Moderna covid-19 vaccine. On 05-Dec-2024, the patient received sixth dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter. On 01-Feb-2025, after starting mRNA-1273.712 (SPIKEVAX 2024-2025 PFS), the patient experienced COVID-19 (got the vaccine in December and now has COVID). At the time of the report, COVID-19 (got the vaccine in December and now has COVID) had not resolved. Concomitant product use was not provided by the reporter. Patient had no other vaccine on the same day as receiving Spikevax. Treatment information was not provided. Reporter causality was not reported. Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2025: Live non-significant follow-up received: reference number added.